Back to Rankings

CRL

Charles River Laboratories InternationalA
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
CRL vs peer average
87/100
CRL vs. peer average (A vs. C)
Grade spread
B 3 · C 2 · D 4 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

LH is the first available peer comparator.

More direct operating comparator for CRL than broad biotech peers because Labcorp has drug-development and preclinical CRO exposure that overlaps with Charles River's DSA safety-assessment demand, although Labcorp's diagnostics business makes the overall company mix less clean.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerLHLabcorp
CRL
Charles River Laboratories International
LH
Labcorp
Grade
A
B
Momentum
91
41
Value
62
61
Sentiment
45
58
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs LH

CRL / LH
Grade Position
Above peers
CRL vs. peer average (A vs. C)
87/100
Momentum
91
CRL
Value
62
CRL
Sentiment
45
LH

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CRL
1
LH
LH
B
80/100
+1
2
IQV
IQV
C
60/100
+2
3
SMMT
Summit Therapeutics Inc Common
D
40/100
+3
4
RDY
Dr. Reddy's Laboratories Ltd ADR
D
40/100
+3
5
APGE
Apogee Therapeutics Inc Common
D
40/100
+3
LH is the first peer returned for this comparison set.